image dons

I make a donation

EVA-G-TAVI

Usefullness of geriatric evaluation to predict mortality, functional prognosis and the quality of life after percutaneous implant of a valvular aortic prosthesis in patients aged over 75

Terminée

La Grande Journée du Coeur (22 juin 2022)
Attention : plus que quelques places restantes !

Colloquium : Pathologies cardiaques de la femme (15 novembre 2022)
Inscriptions ouvertes !

logo étude

objectif

Usefullness of geriatric evaluation to predict mortality, functional prognosis and the quality of life after percutaneous implant of a valvular aortic prosthesis in patients aged over 75.

date de réalisation

2015

nombre de patients

500

nombre de centres participants

14 TAVI implant centers and 13 geriatric centers in France

type de financement

Public (AOM)

Référence

NCT02424370

Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation (EVA-G-TAVI)

Study Description

Transcutaneous trans-aortic valve replacement (TAVR) is now a common procedure to treat symptomatic aortic stenosis. Although as effective and safe as surgical aortic valve replacement, it is still restricted to high surgical risk patient who are frail. The aim of the TAVI-EVA is to identify geriatric biomarkers that may help to predict survival and functional recovery after TAVR.

source clinicaltrials.gov

Autres études

+

EDUC-DAI

En cours


Impact of therapeutic education on the quality of life and the anxiety of patients with a defibrillator.
+

AMUNDSEN

En cours


A phase IV, multicentric, randomized, real-world pragmatic study that compares a strategy of early LDL reduction with anti-PCSK9 in patients defined as extreme high risk by 2019 ESC/EAS guidelines vs....
+

AFLOAT

En cours


To assess if flecainide is more efficient than standard of care (control group) to prevent AF occurrence during the 3 months after PFO closure.